Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taira Maekawa

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Research ethics and conflicts of interest]Taira Maekawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Cell-cycle regulators as molecular target]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Conflicts-of-interests in medical research: its management and current status]Taira Maekawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 16, 2013
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 12. Blood transfusion and adverse events--an unrecognized and underestimated clinico-pathological condition]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Ethics for clinical researchTaira Maekawa
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 23, 2004
[Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2004
[Establishment of institutional GMP cell processing is mandatory for the development of novel advanced cell and gene therapy]Taira Maekawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2007
[Innovation of clinical trials for anti-cancer drugs in Japan--proposals from academia with special reference to the development of novel Bcr-Abl/Lyn tyrosine kinase inhibitor INNO-406 (NS-187) for imatinib-resistant chronic myelogenous leukemia]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 7, 2008
[Delayed hemolytic transfusion reaction (DHTR)--unrecognized and underestimated clinico-pathological conditions]Taira Maekawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 4, 2007
[Overcoming imatinib resistance]Eishi Ashihara, Taira Maekawa
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Research ethics and conflicts of interest]Taira Maekawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Cell-cycle regulators as molecular target]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Conflicts-of-interests in medical research: its management and current status]Taira Maekawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 16, 2013
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 12. Blood transfusion and adverse events--an unrecognized and underestimated clinico-pathological condition]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Ethics for clinical researchTaira Maekawa
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 23, 2004
[Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2004
[Establishment of institutional GMP cell processing is mandatory for the development of novel advanced cell and gene therapy]Taira Maekawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2007
[Innovation of clinical trials for anti-cancer drugs in Japan--proposals from academia with special reference to the development of novel Bcr-Abl/Lyn tyrosine kinase inhibitor INNO-406 (NS-187) for imatinib-resistant chronic myelogenous leukemia]Taira Maekawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 7, 2008
[Delayed hemolytic transfusion reaction (DHTR)--unrecognized and underestimated clinico-pathological conditions]Taira Maekawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 4, 2007
[Overcoming imatinib resistance]Eishi Ashihara, Taira Maekawa
Pageof 16